204 related articles for article (PubMed ID: 26045790)
1. Combination of metformin and valproic acid synergistically induces cell cycle arrest and apoptosis in clear cell renal cell carcinoma.
Zhang X; Zhang X; Huang T; Geng J; Liu M; Zheng J
Int J Clin Exp Pathol; 2015; 8(3):2823-8. PubMed ID: 26045790
[TBL] [Abstract][Full Text] [Related]
2. Combined Treatment with Valproic Acid and 5-Aza-2'-Deoxycytidine Synergistically Inhibits Human Clear Cell Renal Cell Carcinoma Growth and Migration.
Xi W; Chen X; Sun J; Wang W; Huo Y; Zheng G; Wu J; Li Y; Yang A; Wang T
Med Sci Monit; 2018 Feb; 24():1034-1043. PubMed ID: 29457966
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid sensitizes metformin-resistant human renal cell carcinoma cells by upregulating H3 acetylation and EMT reversal.
Wei M; Mao S; Lu G; Li L; Lan X; Huang Z; Chen Y; Zhao M; Zhao Y; Xia Q
BMC Cancer; 2018 Apr; 18(1):434. PubMed ID: 29665787
[TBL] [Abstract][Full Text] [Related]
4. Effects of combined valproic acid and the epidermal growth factor/vascular endothelial growth factor receptor tyrosine kinase inhibitor AEE788 on renal cell carcinoma cell lines in vitro.
Juengel E; Engler J; Mickuckyte A; Jones J; Hudak L; Jonas D; Blaheta RA
BJU Int; 2010 Feb; 105(4):549-57. PubMed ID: 19594733
[TBL] [Abstract][Full Text] [Related]
5. Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells.
Xie W; Wang L; Sheng H; Qiu J; Zhang D; Zhang L; Yang F; Tang D; Zhang K
Med Sci Monit; 2017 Jan; 23():29-37. PubMed ID: 28045889
[TBL] [Abstract][Full Text] [Related]
6. Metformin Induces Different Responses in Clear Cell Renal Cell Carcinoma Caki Cell Lines.
Pasha M; Sivaraman SK; Frantz R; Agouni A; Munusamy S
Biomolecules; 2019 Mar; 9(3):. PubMed ID: 30909494
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid induces p21 and topoisomerase-II (alpha/beta) expression and synergistically enhances etoposide cytotoxicity in human glioblastoma cell lines.
Das CM; Aguilera D; Vasquez H; Prasad P; Zhang M; Wolff JE; Gopalakrishnan V
J Neurooncol; 2007 Nov; 85(2):159-70. PubMed ID: 17534580
[TBL] [Abstract][Full Text] [Related]
8. Metformin inhibits renal cell carcinoma in vitro and in vivo xenograft.
Liu J; Li M; Song B; Jia C; Zhang L; Bai X; Hu W
Urol Oncol; 2013 Feb; 31(2):264-70. PubMed ID: 21676631
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine.
Wu XX; Ogawa O; Kakehi Y
Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592
[TBL] [Abstract][Full Text] [Related]
10. Synergistically killing activity of aspirin and histone deacetylase inhibitor valproic acid (VPA) on hepatocellular cancer cells.
Li X; Zhu Y; He H; Lou L; Ye W; Chen Y; Wang J
Biochem Biophys Res Commun; 2013 Jun; 436(2):259-64. PubMed ID: 23726914
[TBL] [Abstract][Full Text] [Related]
11. Effect of metformin on the proliferation and apoptosis of the renal cancer cell line 786-O and the underlying mechanisms.
Zhong ZH; Zhong ZY; Zhu ZT; Li C; Zhang CY; Tong M; Jiang HM
J BUON; 2015; 20(5):1244-9. PubMed ID: 26537071
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of beta1 integrins in renal carcinoma cell lines exposed to the differentiation inducer valproic acid.
Oertl A; Relja B; Makarevic J; Weich E; Höfler S; Jones J; Jonas D; Bratzke H; Baer PC; Blaheta RA
Int J Mol Med; 2006 Aug; 18(2):347-54. PubMed ID: 16820945
[TBL] [Abstract][Full Text] [Related]
13. Combined valproic acid and celecoxib treatment induced synergistic cytotoxicity and apoptosis in neuroblastoma cells.
Chen Y; Tsai YH; Tseng SH
Anticancer Res; 2011 Jun; 31(6):2231-9. PubMed ID: 21737646
[TBL] [Abstract][Full Text] [Related]
14. The selective MEK1 inhibitor Selumetinib enhances the antitumor activity of everolimus against renal cell carcinoma in vitro and in vivo.
Zou Y; Wang J; Leng X; Huang J; Xue W; Zhang J; Huang Y
Oncotarget; 2017 Mar; 8(13):20825-20833. PubMed ID: 28212559
[TBL] [Abstract][Full Text] [Related]
15. Synergistic anti-proliferative effect of metformin and sorafenib on growth of anaplastic thyroid cancer cells and their stem cells.
Chen G; Nicula D; Renko K; Derwahl M
Oncol Rep; 2015 Apr; 33(4):1994-2000. PubMed ID: 25683253
[TBL] [Abstract][Full Text] [Related]
16. Dauricine inhibits viability and induces cell cycle arrest and apoptosis via inhibiting the PI3K/Akt signaling pathway in renal cell carcinoma cells.
Zhang S; Ren Y; Qiu J
Mol Med Rep; 2018 May; 17(5):7403-7408. PubMed ID: 29568902
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of anticancer effect of valproic acid, an antiepileptic agent with histone deacetylase inhibitory activity, by the cyclin-dependent kinase inhibitor P276-00 in human non-small-cell lung cancer cell lines.
Shirsath N; Rathos M; Chaudhari U; Sivaramakrishnan H; Joshi K
Lung Cancer; 2013 Nov; 82(2):214-21. PubMed ID: 24051085
[TBL] [Abstract][Full Text] [Related]
18. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells.
Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma agonists potentiate the cytotoxic effect of valproic acid in multiple myeloma cells.
Aouali N; Palissot V; El-Khoury V; Moussay E; Janji B; Pierson S; Brons NH; Kellner L; Bosseler M; Van Moer K; Berchem G
Br J Haematol; 2009 Dec; 147(5):662-71. PubMed ID: 19793255
[TBL] [Abstract][Full Text] [Related]
20. [Effect of metformin on apoptosis of renal cell carcinoma cells in vitro and its mechanisms].
Li M; Liu J; Hu WL; Jia CH; Li HY; Wen ZH; Zou ZP; Bai XC; Luo SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Sep; 31(9):1504-8. PubMed ID: 21945753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
